As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move
ASCO, NCCS Call For Oncology Center
Zerhouni Appoints Two Institute Directors
ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard
NCI Program Develops Bioinformatics Tool To Design Cancer Drugs
Funding Opportunities
Trending Stories
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- Cancer Moonshot contributes additional $100M to reduce cancer burden in Africa
- A view from the BMT unit on the day a Russian cruise missile hit Kyiv’s Ohmatdyt hospital
- Proposed rule by CMS would expand access to cancer treatment at tribal facilities